Recent advances and challenges of cellular immunotherapies in lung cancer treatment
Abstract Lung cancer is a major malignant tumor with high morbidity and fatality rates. For many years, traditional treatments for lung cancer have struggled to achieve a favorable outlook and prognosis. It is crucial to identify and innovate novel clinical therapeutic strategies and techniques to p...
Saved in:
| Main Authors: | Chengfei Yang, Yue Liu, Ziqi Huang, Sijin Liu, Xi Zhang, Quanxing Liu, Jigang Dai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Experimental Hematology & Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40164-025-00679-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nano-immunotherapy for lung cancer
by: Yuting Lu, et al.
Published: (2023-03-01) -
Nanomaterials Mediated Enhancement of CAR-T for HCC: Revolutionizing Immunotherapy Strategies
by: Liu X, et al.
Published: (2025-06-01) -
Engineering a controllable and reversible switch for CAR-based cellular immunotherapies via a genetic code expansion system
by: Yue Liu, et al.
Published: (2024-12-01) -
Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases
by: Mingwei Jiang, et al.
Published: (2025-12-01) -
The hotspots and publication trends in glioblastoma and CAR-T immunotherapy: A bibliometric analysis
by: Zhaoming Song, et al.
Published: (2025-12-01)